Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology

• Main Authors: Zhitong Bing (Author), Zhiyuan Cheng (Author), Danfeng Shi (Author), Xinkui Liu (Author), Jinhui Tian (Author), Xiaojun Yao (Author), Jingyun Zhang (Author), Yongfeng Wang (Author), Kehu Yang (Author)
• Format: Book
• Published: BMC, 2018-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Chinese traditional herbal medicine Fuzhengkangai (FZKA) formulation combination with gefitinib can overcome drug resistance and improve the prognosis of lung adenocarcinoma patients. However, the pharmacological and molecular mechanisms underlying the active ingredients, potenti...